Therapeutics


Current Solutions & typical limitations

Currently administered via numerous routes, each with their own limitations such as first pass metabolism, painful injections and in the case of transdermal delivery, limited to a select few therapeutics exhibiting ideal physiochemical properties.

Key Pharma Latch benefits

  • Amenable to therapeutics that are less potent & require higher doses
  • Self-adhering – no need for adhesives
  • Improved patient adherence for chronic conditions

Biologics


Current Solutions & typical limitations

Biologics (such as proteins and peptides) are most commonly delivered parenterally, with long term and/or repeated administration via this traditional route associated with disadvantages and potential complications1. Injections can be painful and distressing for those who are needle phobic, which in turn may contribute to reduced patient compliance.

Key Pharma Latch benefits

  • Easy to use & self-administered
  • Potential for sustained release & reduction in need for repeated injection
  • Coated at room temperature
  • Improved patient adherence for chronic conditions

Vaccines


Current Solutions & typical limitations

The majority of vaccines are currently delivered via intramuscular or subcutaneous injection, with a small number via intradermal injection. Intradermal injection is difficult to perform and requires a substantial amount of training, thus can only be performed by qualified personnel.

Key Pharma Latch benefits

  • Precision depth of penetration
  • Potential for dose sparing & improved immunogenicity
  • Repeatable accurate dosing
  • Substantially less training required

Therapeutics

Current Solutions & typical limitations

Key Pharma Latch benefits

Currently administered via numerous routes, each with their own limitations such as first pass metabolism, painful injections and in the case of transdermal delivery, limited to a select few therapeutics exhibiting ideal physiochemical properties.
  • Amenable to therapeutics that are less potent & require higher doses
  • Self-adhering – no need for adhesives
  • Improved patient adherence for chronic conditions

Biologics

Current Solutions & typical limitations

Key Pharma Latch benefits

Biologics (such as proteins and peptides) are most commonly delivered parenterally, with long term and/or repeated administration via this traditional route associated with disadvantages and potential complications1. Injections can be painful and distressing for those who are needle phobic, which in turn may contribute to reduced patient compliance.
  • Easy to use & self-administered
  • Potential for sustained release & reduction in need for repeated injection
  • Coated at room temperature
  • Improved patient adherence for chronic conditions

Vaccines

Current Solutions & typical limitations

Key Pharma Latch benefits

The majority of vaccines are currently delivered via intramuscular or subcutaneous injection, with a small number via intradermal injection. Intradermal injection is difficult to perform and requires a substantial amount of training, thus can only be performed by qualified personnel.
  • Precision depth of penetration
  • Potential for dose sparing & improved immunogenicity
  • Repeatable accurate dosing
  • Substantially less training required

Currently looking for partnerships

Partner with us!

Get in Touch

If you would like to find out more about our revolutionary Pharma Latch solution, please contact us
at +353 1 7163770 or info@pharmalatch.com.

Call Us   Email Us
undefined